Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
imu-838 (7 trials)
oseltamivir (tamiflu) (1 trial)
imu-935 (1 trial)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Coronavirus Infections (Phase 3)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Sclerosis (Phase 2)
Ulcer (Phase 2)
Trials (8 total)
Trial APIs (3 total)